International union of basic and clinical pharmacology. CXII: adenosine receptors: a further update

AP IJzerman, KA Jacobson, CE Müller… - Pharmacological …, 2022 - ASPET
Our previous International Union of Basic and Clinical Pharmacology report on the
nomenclature and classification of adenosine receptors (2011) contained a number of …

Understanding the neural mechanisms of general anesthesia from interaction with sleep–wake state: a decade of discovery

WW Bao, S Jiang, WM Qu, WX Li, CH Miao… - Pharmacological …, 2023 - ASPET
The development of cutting-edge techniques to study specific brain regions and neural
circuits that regulate sleep–wake brain states and general anesthesia (GA), has increased …

Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways

PR Jansen, K Watanabe, S Stringer, N Skene… - Nature …, 2019 - nature.com
Insomnia is the second most prevalent mental disorder, with no sufficient treatment
available. Despite substantial heritability, insight into the associated genes and …

Nucleus accumbens controls wakefulness by a subpopulation of neurons expressing dopamine D1 receptors

YJ Luo, YD Li, L Wang, SR Yang, XS Yuan… - Nature …, 2018 - nature.com
Nucleus accumbens (NAc) is involved in behaviors that depend on heightened wakefulness,
but its impact on arousal remains unclear. Here, we demonstrate that NAc dopamine D1 …

Genome-wide association analysis of self-reported daytime sleepiness identifies 42 loci that suggest biological subtypes

H Wang, JM Lane, SE Jones, HS Dashti… - Nature …, 2019 - nature.com
Excessive daytime sleepiness (EDS) affects 10–20% of the population and is associated
with substantial functional deficits. Here, we identify 42 loci for self-reported daytime …

[图书][B] Sleep disorders medicine E-Book: Basic science, technical considerations, and clinical aspects

S Chokroverty - 2009 - books.google.com
Dr. Sudhansu Chokroverty—a world-recognized expert in sleep medicine—presents the
third edition of Sleep Disorders Medicine for the latest developments in this rapidly …

The control of sleep and wakefulness by mesolimbic dopamine systems

Y Oishi, M Lazarus - Neuroscience research, 2017 - Elsevier
The mesolimbic dopamine pathway between the ventral tegmental area (VTA) and the
nucleus accumbens (NAc) plays a central role in motivational behaviors. Recent findings …

Ventral pallidal GABAergic neurons control wakefulness associated with motivation through the ventral tegmental pathway

YD Li, YJ Luo, W Xu, J Ge, Y Cherasse, YQ Wang… - Molecular …, 2021 - nature.com
The ventral pallidum (VP) regulates motivation, drug addiction, and several behaviors that
rely on heightened arousal. However, the role and underlying neural circuits of the VP in the …

Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models

Y Irukayama-Tomobe, Y Ogawa… - Proceedings of the …, 2017 - National Acad Sciences
Narcolepsy-cataplexy is a debilitating disorder of sleep/wakefulness caused by a loss of
orexin-producing neurons in the lateroposterior hypothalamus. Genetic or pharmacologic …

40 Hz light flickering promotes sleep through cortical adenosine signaling

X Zhou, Y He, T Xu, Z Wu, W Guo, X Xu, Y Liu, Y Zhang… - Cell Research, 2024 - nature.com
Flickering light stimulation has emerged as a promising non-invasive neuromodulation
strategy to alleviate neuropsychiatric disorders. However, the lack of a neurochemical …